The biopharma sector is likely to see dampened returns over the next five years, with increasing headwinds in the years beyond

/PRNewswire/ -- Biopharma companies have enjoyed 30 years of high productivity, with average total shareholder return (TSR) growing at a compound annual rate...

Related Keywords

Eli Weinberg ,Prnewswire Biopharma ,Bain Company ,Biopharma Productivity ,Katie Ware ,